111 related articles for article (PubMed ID: 7919994)
1. Thyroid hormone and bone mass: the clinician's dilemma.
Baran DT
Thyroid; 1994; 4(2):143-4. PubMed ID: 7919994
[No Abstract] [Full Text] [Related]
2. [Thyroid hormone and bone mass].
Nóvoa Mogollón FJ
Med Clin (Barc); 1994 Nov; 103(18):695-6. PubMed ID: 7808076
[No Abstract] [Full Text] [Related]
3. Use of sensitive TSH assay to determine optimal thyroid hormone therapy and avoid osteoporosis.
Wartofsky L
Annu Rev Med; 1991; 42():341-5. PubMed ID: 2035978
[TBL] [Abstract][Full Text] [Related]
4. [Increased risk of osteoporosis in thyroid hormone substitution therapy].
Límanová Z; Stĕpán J
Cas Lek Cesk; 1990 May; 129(20):625-7. PubMed ID: 2354492
[TBL] [Abstract][Full Text] [Related]
5. Influence of clinical characteristics and parameters associated with thyroid hormone therapy on the bone mineral density of women treated with thyroid hormone.
Duncan WE; Chang A; Solomon B; Wartofsky L
Thyroid; 1994; 4(2):183-90. PubMed ID: 7920001
[TBL] [Abstract][Full Text] [Related]
6. Impact on bone of thyroid hormone therapy.
Lauwers A; Alexandre C
Rev Rhum Engl Ed; 1997 Feb; 64(2):112-9. PubMed ID: 9085446
[TBL] [Abstract][Full Text] [Related]
7. Thyroid disease and osteoporosis.
Burman KD
Hosp Pract (1995); 1997 Dec; 32(12):71-3, 78-85; discussion 85-6. PubMed ID: 12828358
[TBL] [Abstract][Full Text] [Related]
8. [The influence of thyrotoxicosis and thyroxine therapy on the risk of osteoporosis].
Zatońska K; Bolanowski M
Pol Merkur Lekarski; 2000 May; 8(47):356-9. PubMed ID: 10944962
[TBL] [Abstract][Full Text] [Related]
9. [Principles of thyroid hormone treatment (author's transl)].
Pfannenstiel P
MMW Munch Med Wochenschr; 1980 Jun; 122(26):961-6. PubMed ID: 6775193
[TBL] [Abstract][Full Text] [Related]
10. [The risk for osteoporosis in persons treated with thyroid hormones].
Límanová Z; Stĕpán J
Vnitr Lek; 1992 Sep; 38(9):860-7. PubMed ID: 1481384
[TBL] [Abstract][Full Text] [Related]
11. Thyroid-hormone therapy and thyroid cancer: a reassessment.
Biondi B; Filetti S; Schlumberger M
Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):32-40. PubMed ID: 16929364
[TBL] [Abstract][Full Text] [Related]
12. [Bone risk of hormone-suppressing therapy in differentiated thyroid epithelioma. Study by dual photon absorptiometry].
Leprat F; Austyn C; Commenges-Ducos M; Commenges D; Cochet C; Basse-Catalinat B; Ducassou D; Latapie JL
Ann Endocrinol (Paris); 1992; 53(5-6):224-9. PubMed ID: 1340689
[TBL] [Abstract][Full Text] [Related]
13. [Proceedings: Termination of thyroid hormone therapy following radical surgery of differentiated cancer of the thyroid].
Fujimoto Y; Oka A; Fukumitsu M; Tanaka T; Abe K
Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):378. PubMed ID: 4476467
[No Abstract] [Full Text] [Related]
14. Thyroid hormones and bone mass.
Baran DT; Braverman LE
J Clin Endocrinol Metab; 1991 Jun; 72(6):1182-3. PubMed ID: 2026739
[No Abstract] [Full Text] [Related]
15. Thyroid hormone use and bone mineral density in elderly men.
Schneider DL; Barrett-Connor EL; Morton DJ
Arch Intern Med; 1995 Oct; 155(18):2005-7. PubMed ID: 7575055
[TBL] [Abstract][Full Text] [Related]
16. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.
Marcocci C; Golia F; Bruno-Bossio G; Vignali E; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):818-23. PubMed ID: 8157704
[TBL] [Abstract][Full Text] [Related]
17. [Hyperthyroidism caused by treatment with thyroid preparations].
Misztela G; Gasiorowski W
Pol Tyg Lek; 1983 Apr; 38(16):485-7. PubMed ID: 6634493
[No Abstract] [Full Text] [Related]
18. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
Marcocci C; Golia F; Vignali E; Pinchera A
J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
[TBL] [Abstract][Full Text] [Related]
20. [Value of thyroid hormone and hypophyseal thyrostimulin determination and the thyrotropin releasing hormone test in the surveillance of thyroid cancer].
Sulman C; Gosselin P; Carpentier P
Lille Med; 1979 Nov; 24(9):689-92. PubMed ID: 119121
[No Abstract] [Full Text] [Related]
[Next] [New Search]
